10 Biggest Price Target Changes For Tuesday
Benzinga2022-01-25
- Needham cut Medtronic plc price target from $131 to $128. Medtronic shares fell 0.7% to $103.44 in pre-market trading.
- Deutsche Bank cut Bill.com Holdings, Inc. price target from $360 to $265. Bill.com shares fell 4.2% to $159.80 in pre-market trading.
- Stifel lowered Blueprint Medicines Corporation price target from $120 to $95. Blueprint Medicines shares rose 1.8% to $73.59 in pre-market trading.
- Berenberg raised the price target for Delta Air Lines, Inc. from $48 to $50. Delta Air shares fell 0.4% to $37.76 in pre-market trading.
- Keybanc reduced the price target on Intuit Inc. from $750 to $700. Intuit shares fell 0.3% to $532.99 in pre-market trading.
- SVB Leerink boosted Allscripts Healthcare Solutions, Inc. price target from $19 to $22. Allscripts Healthcare shares rose 4% to $18.18 in pre-market trading.
- JMP Securities cut the price target on eFFECTOR Therapeutics, Inc. from $33 to $8. eFFECTOR Therapeutics shares fell 6.1% to close at $6.03 on Monday.
- Keybanc lowered the price target for Shopify Inc. from $1,750 to $1,250. Shopify shares fell 2.2% to $918.00 in pre-market trading.
- Mizuho cut Fidelity National Information Services, Inc. price target from $160 to $150. Fidelity National Information shares fell 0.1% to $111.74 in pre-market trading.
- Needham lowered the price target on Wayfair Inc. from $280 to $225. Wayfair shares fell 3.1% to $148.00 in pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.